Year To Quarter End Consolidated Statement Of Comprehensive Income

Carna Biosciences, Inc. - Filing #7586726

Concept 2022-01-01 to
2022-09-30
2021-01-01 to
2021-09-30
Year to quarter end consolidated statement of comprehensive income
Statement of comprehensive income
Profit (loss)
-795,218,000 JPY
-1,178,075,000 JPY
Other comprehensive income
Valuation difference on available-for-sale securities
-1,716,000 JPY
-412,000 JPY
Deferred gains or losses on hedges
30,787,000 JPY
4,624,000 JPY
Foreign currency translation adjustment
47,369,000 JPY
11,596,000 JPY
Other comprehensive income
76,440,000 JPY
15,809,000 JPY
Comprehensive income
-718,777,000 JPY
-1,162,265,000 JPY
Comprehensive income attributable to
Comprehensive income attributable to owners of parent
-718,777,000 JPY
-1,162,265,000 JPY
Comprehensive income attributable to non-controlling interests
JPY
JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.